neurotranslation:
Our CAPABILITIES
The following highlights the capabilities of the BSi NeuroTranslational Drug Discovery Program staff:
- Design, synthesis, purification, and characterization of small molecule drug candidates
- Hit identification, hit-to-lead selection and lead optimization
- High throughput screening assay development
- Receptor pharmacology
- Enzyme kinetics and mechanisms
- Primary cell culture and establishment of cell lines
- Preclinical toxicology
- Drug metabolism and pharmacokinetics
- Investigational New Drug (IND) enabling preclinical studies
- FDA regulatory filing
- Intellectual property creation
